TENAX THERAPEUTICS INC (TENX)

US88032L6056 - Common Stock

3.6  +0.04 (+1.12%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
0.000.000.000.000.00
Cost Of Goods
N/AN/AN/AN/AN/A
Gross Profit
N/AN/AN/AN/AN/A
Operating Expenses
8.23M11.05M32.73M9.87M8.56M
Research and Development
3.23M5.38M25.15M4.56M3.47M
Selling, General, and Administrative Expenses
5.01M5.68M7.58M5.31M5.08M
Operating Income
-8.23M-11.05M-32.73M-9.87M-8.56M
Interest Income/Expense
-23.97K0.000.000.00N/A
Other Income/Expense
547.24K10.00K-250.00K20.00K160.00K
Non Recurring Items
N/AN/A0.00N/AN/A
Income Before Taxes
-7.71M-11.05M-32.98M-9.85M-8.39M
Income Tax
N/AN/AN/AN/AN/A
Net Income
-7.71M-11.05M-32.98M-9.85M-8.39M
EBITDA
-8.23M-11.04MN/AN/A-8.55M
 
Per Share Data
EPS Diluted Total Ops
-31.04-7.51-32.01-26.62-27.06
Non GAAP EPS
-35.38N/A-7.44-1.39-1.35
 
Statistics
Gross Profit Margin
N/AN/AN/AN/AN/A
Profit Margin
N/AN/AN/AN/AN/A
Operating Profit Margin
N/AN/AN/AN/AN/A

All data in USD

Charts